Simplicity Wealth’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$488K Buy
2,259
+110
+5% +$21K 0.02% 650
2026
Q1
$394K Buy
2,149
+197
+10% +$36.3K 0.02% 519
2025
Q4
$344K Buy
1,952
+176
+10% +$28.8K 0.02% 519
2025
Q3
$249K Sell
1,776
-1,648
-48% -$223K 0.01% 612
2025
Q2
$430K Buy
+3,424
New +$427K 0.02% 491
2024
Q3
Sell
-1,831
Closed -$424K 556
2024
Q2
$424K Sell
1,831
-232
-11% -$50.4K 0.01% 820
2024
Q1
$445K Buy
+2,063
New +$483K 0.01% 779

Other funds holding BIIB

Simplicity Wealth's BIIB Position: Q2 2026 in Review

Simplicity Wealth increased its Biogen (BIIB) stake by 5.1% in Q2 2026, buying an estimated $21K and bringing the position to 2,259 shares worth $488K. The position accounts for 0.02% of the portfolio, ranked #650.

Simplicity Wealth first reported a position in BIIB in Q1 2024 and has held it in 7 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Simplicity Wealth held 2,259 shares of Biogen worth $488K as of Q2 2026.
  • Simplicity Wealth bought 110 Biogen shares in Q2 2026, an estimated $21K.
  • Biogen made up 0.02% of Simplicity Wealth's portfolio in Q2 2026, its #650 holding.
  • Simplicity Wealth first reported a position in Biogen in Q1 2024 and has held it in 7 quarters since.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Simplicity Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.